Common Stock, Shares, Outstanding of Theriva Biologics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Theriva Biologics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Theriva Biologics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 35,688,350, a 1183% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Theriva Biologics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 35,688,350 +32,905,901 +1183% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 10,304,762 +7,687,300 +294% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 9,059,232 -13,333,926 -60% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 2,782,449 -14,365,600 -84% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 2,782,449 +2,096,230 +305% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 2,617,462 -14,425,303 -85% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 22,393,158 +5,351,381 +31% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 17,148,049 +2,023,988 +13% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 686,219 -14,437,609 -95% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 17,042,765 +1,198,704 +7.6% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 17,041,777 +1,197,716 +7.6% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 15,124,061 -143,313,779 -90% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 15,123,828 +1,919,574 +15% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 15,844,061 -116,198,477 -88% 30 Sep 2022 10-K 30 Mar 2023 2022 FY
Q2 2022 15,844,061 -116,198,477 -88% 30 Jun 2022 10-K 30 Mar 2023 2022 FY
Q1 2022 158,437,840 +26,395,302 +20% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 13,204,254 -16,045,671 -55% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 132,042,538 +112,199,583 +565% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 132,042,538 +113,398,714 +608% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 132,042,538 +114,303,063 +644% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 29,249,925 +12,443,495 +74% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 19,842,955 +3,036,525 +18% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 18,643,824 +1,998,264 +12% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 17,739,475 +1,356,523 +8.3% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 16,806,430 +1,324,347 +8.6% 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 16,806,430 +11,462,084 +214% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 16,645,560 -113,653,745 -87% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 16,382,952 -112,183,934 -87% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 15,482,083 +11,811,069 +322% 31 Dec 2018 10-K 20 Feb 2020 2019 FY
Q3 2018 5,344,346 -123,222,537 -96% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 130,299,305 +2,553,209 +2% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 128,566,886 +10,630,675 +9% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 3,671,014 -113,501,700 -97% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 128,566,883 +36,914,532 +40% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 127,746,096 +36,476,510 +40% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 117,936,211 +27,109,459 +30% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 117,172,714 +26,345,962 +29% 31 Dec 2016 10-K 22 Feb 2018 2017 FY
Q3 2016 91,652,351 +842,265 +0.93% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 91,269,586 +18,090,281 +25% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 90,826,752 +18,019,283 +25% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 90,826,752 +18,313,608 +25% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q3 2015 90,810,086 +32,356,558 +55% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 73,179,305 +14,725,777 +25% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 72,807,469 +14,364,899 +25% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 72,513,144 +14,298,818 +25% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q3 2014 58,453,528 +13,799,114 +31% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 58,453,528 +13,799,114 +31% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 58,442,570 +13,788,156 +31% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 58,214,326 +13,851,578 +31% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 44,654,414 +11,258,876 +34% 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 44,654,414 +11,353,267 +34% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 44,654,414 +11,878,287 +36% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 44,362,748 +13,070,228 +42% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 33,395,538 +5,186,412 +18% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 33,301,147 +5,303,503 +19% 30 Jun 2012 10-Q/A 11 Sep 2012 2012 Q2
Q1 2012 32,776,127 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 31,292,520 +7,953,813 +34% 31 Dec 2011 10-K 16 Apr 2013 2012 FY
Q3 2011 28,209,126 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 27,997,644 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 23,338,707 31 Dec 2010 10-K/A 11 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.